Form 8-K - Current report:
SEC Accession No. 0001125345-24-000090
Filing Date
2024-05-09
Accepted
2024-05-09 16:05:16
Documents
31
Period of Report
2024-05-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20240509.htm   iXBRL 8-K 26614
2 EX-99.1 macrogenicstamarackinter.htm EX-99.1 22415
6 macrogenicstamarackinter001.jpg GRAPHIC 86807
7 macrogenicstamarackinter002.jpg GRAPHIC 296350
8 macrogenicstamarackinter003.jpg GRAPHIC 106702
9 macrogenicstamarackinter004.jpg GRAPHIC 77585
10 macrogenicstamarackinter005.jpg GRAPHIC 138223
11 macrogenicstamarackinter006.jpg GRAPHIC 85009
12 macrogenicstamarackinter007.jpg GRAPHIC 157515
13 macrogenicstamarackinter008.jpg GRAPHIC 113364
14 macrogenicstamarackinter009.jpg GRAPHIC 111305
15 macrogenicstamarackinter010.jpg GRAPHIC 112684
16 macrogenicstamarackinter011.jpg GRAPHIC 113848
17 macrogenicstamarackinter012.jpg GRAPHIC 132577
18 macrogenicstamarackinter013.jpg GRAPHIC 135784
19 macrogenicstamarackinter014.jpg GRAPHIC 128686
20 macrogenicstamarackinter015.jpg GRAPHIC 158588
21 macrogenicstamarackinter016.jpg GRAPHIC 103449
22 macrogenicstamarackinter017.jpg GRAPHIC 128949
  Complete submission text file 0001125345-24-000090.txt   3193886

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20240509.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20240509_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20240509_pre.xml EX-101.PRE 12508
34 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20240509_htm.xml XML 2717
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 24930406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)